Global Lysosomal Alpha Glucosidase Market Research Report 2024

Report ID: 1970021 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Lysosomal Alpha Glucosidase Market Overview
    1.1 Product Overview and Scope of Lysosomal Alpha Glucosidase
    1.2 Lysosomal Alpha Glucosidase Segment by Type
        1.2.1 Global Lysosomal Alpha Glucosidase Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 AT-982
        1.2.3 ATB-200
        1.2.4 AVRRD-03
        1.2.5 JR-162
        1.2.6 MOSS-GAA
        1.2.7 OXY-2810
        1.2.8 Others
    1.3 Lysosomal Alpha Glucosidase Segment by Application
        1.3.1 Global Lysosomal Alpha Glucosidase Sales Comparison by Application: (2022-2028)
        1.3.2 Glycogen Storage Disease
        1.3.3 Pompe Disease
        1.3.4 Others
    1.4 Global Lysosomal Alpha Glucosidase Market Size Estimates and Forecasts
        1.4.1 Global Lysosomal Alpha Glucosidase Revenue 2017-2028
        1.4.2 Global Lysosomal Alpha Glucosidase Sales 2017-2028
        1.4.3 Lysosomal Alpha Glucosidase Market Size by Region: 2017 Versus 2021 Versus 2028
2 Lysosomal Alpha Glucosidase Market Competition by Manufacturers
    2.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Lysosomal Alpha Glucosidase Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Lysosomal Alpha Glucosidase Manufacturing Sites, Area Served, Product Type
    2.5 Lysosomal Alpha Glucosidase Market Competitive Situation and Trends
        2.5.1 Lysosomal Alpha Glucosidase Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Lysosomal Alpha Glucosidase Players Market Share by Revenue
        2.5.3 Global Lysosomal Alpha Glucosidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lysosomal Alpha Glucosidase Retrospective Market Scenario by Region
    3.1 Global Lysosomal Alpha Glucosidase Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Lysosomal Alpha Glucosidase Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Lysosomal Alpha Glucosidase Market Facts & Figures by Country
        3.3.1 North America Lysosomal Alpha Glucosidase Sales by Country
        3.3.2 North America Lysosomal Alpha Glucosidase Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Lysosomal Alpha Glucosidase Market Facts & Figures by Country
        3.4.1 Europe Lysosomal Alpha Glucosidase Sales by Country
        3.4.2 Europe Lysosomal Alpha Glucosidase Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Lysosomal Alpha Glucosidase Market Facts & Figures by Region
        3.5.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Region
        3.5.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Lysosomal Alpha Glucosidase Market Facts & Figures by Country
        3.6.1 Latin America Lysosomal Alpha Glucosidase Sales by Country
        3.6.2 Latin America Lysosomal Alpha Glucosidase Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Lysosomal Alpha Glucosidase Market Facts & Figures by Country
        3.7.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country
        3.7.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Lysosomal Alpha Glucosidase Historic Market Analysis by Type
    4.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
    4.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2017-2022)
    4.3 Global Lysosomal Alpha Glucosidase Price by Type (2017-2022)
5 Global Lysosomal Alpha Glucosidase Historic Market Analysis by Application
    5.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
    5.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2017-2022)
    5.3 Global Lysosomal Alpha Glucosidase Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Amicus Therapeutics Inc
        6.1.1 Amicus Therapeutics Inc Corporation Information
        6.1.2 Amicus Therapeutics Inc Description and Business Overview
        6.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
        6.1.5 Amicus Therapeutics Inc Recent Developments/Updates
    6.2 Audentes Therapeutics Inc
        6.2.1 Audentes Therapeutics Inc Corporation Information
        6.2.2 Audentes Therapeutics Inc Description and Business Overview
        6.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
        6.2.5 Audentes Therapeutics Inc Recent Developments/Updates
    6.3 Etubics Corp
        6.3.1 Etubics Corp Corporation Information
        6.3.2 Etubics Corp Description and Business Overview
        6.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio
        6.3.5 Etubics Corp Recent Developments/Updates
    6.4 Genzyme Corp
        6.4.1 Genzyme Corp Corporation Information
        6.4.2 Genzyme Corp Description and Business Overview
        6.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio
        6.4.5 Genzyme Corp Recent Developments/Updates
    6.5 greenovation Biotech GmbH
        6.5.1 greenovation Biotech GmbH Corporation Information
        6.5.2 greenovation Biotech GmbH Description and Business Overview
        6.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio
        6.5.5 greenovation Biotech GmbH Recent Developments/Updates
    6.6 Huons Co Ltd
        6.6.1 Huons Co Ltd Corporation Information
        6.6.2 Huons Co Ltd Description and Business Overview
        6.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
        6.6.5 Huons Co Ltd Recent Developments/Updates
    6.7 JCR Pharmaceuticals Co Ltd
        6.6.1 JCR Pharmaceuticals Co Ltd Corporation Information
        6.6.2 JCR Pharmaceuticals Co Ltd Description and Business Overview
        6.6.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
        6.7.5 JCR Pharmaceuticals Co Ltd Recent Developments/Updates
    6.8 Oxyrane Belgium NV
        6.8.1 Oxyrane Belgium NV Corporation Information
        6.8.2 Oxyrane Belgium NV Description and Business Overview
        6.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio
        6.8.5 Oxyrane Belgium NV Recent Developments/Updates
    6.9 Pharming Group NV
        6.9.1 Pharming Group NV Corporation Information
        6.9.2 Pharming Group NV Description and Business Overview
        6.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio
        6.9.5 Pharming Group NV Recent Developments/Updates
    6.10 Sarepta Therapeutics Inc
        6.10.1 Sarepta Therapeutics Inc Corporation Information
        6.10.2 Sarepta Therapeutics Inc Description and Business Overview
        6.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
        6.10.5 Sarepta Therapeutics Inc Recent Developments/Updates
7 Lysosomal Alpha Glucosidase Manufacturing Cost Analysis
    7.1 Lysosomal Alpha Glucosidase Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Lysosomal Alpha Glucosidase
    7.4 Lysosomal Alpha Glucosidase Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Lysosomal Alpha Glucosidase Distributors List
    8.3 Lysosomal Alpha Glucosidase Customers
9 Lysosomal Alpha Glucosidase Market Dynamics
    9.1 Lysosomal Alpha Glucosidase Industry Trends
    9.2 Lysosomal Alpha Glucosidase Market Drivers
    9.3 Lysosomal Alpha Glucosidase Market Challenges
    9.4 Lysosomal Alpha Glucosidase Market Restraints
10 Global Market Forecast
    10.1 Lysosomal Alpha Glucosidase Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Lysosomal Alpha Glucosidase by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Lysosomal Alpha Glucosidase by Type (2023-2028)
    10.2 Lysosomal Alpha Glucosidase Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Lysosomal Alpha Glucosidase by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Lysosomal Alpha Glucosidase by Application (2023-2028)
    10.3 Lysosomal Alpha Glucosidase Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Lysosomal Alpha Glucosidase by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Lysosomal Alpha Glucosidase by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Lysosomal Alpha Glucosidase Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Lysosomal Alpha Glucosidase Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Lysosomal Alpha Glucosidase Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Lysosomal Alpha Glucosidase Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Lysosomal Alpha Glucosidase Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Lysosomal Alpha Glucosidase Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Lysosomal Alpha Glucosidase Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Lysosomal Alpha Glucosidase Manufacturing Sites and Area Served
    Table 11. Manufacturers Lysosomal Alpha Glucosidase Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Lysosomal Alpha Glucosidase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Alpha Glucosidase as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Lysosomal Alpha Glucosidase Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)
    Table 17. Global Lysosomal Alpha Glucosidase Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2017-2022)
    Table 19. North America Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
    Table 21. North America Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
    Table 23. Europe Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
    Table 25. Europe Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Lysosomal Alpha Glucosidase Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Lysosomal Alpha Glucosidase Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Lysosomal Alpha Glucosidase Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
    Table 33. Latin America Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
    Table 39. Global Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
    Table 41. Global Lysosomal Alpha Glucosidase Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Lysosomal Alpha Glucosidase Revenue Share by Type (2017-2022)
    Table 43. Global Lysosomal Alpha Glucosidase Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Lysosomal Alpha Glucosidase Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
    Table 46. Global Lysosomal Alpha Glucosidase Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Lysosomal Alpha Glucosidase Revenue Share by Application (2017-2022)
    Table 48. Global Lysosomal Alpha Glucosidase Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Amicus Therapeutics Inc Corporation Information
    Table 50. Amicus Therapeutics Inc Description and Business Overview
    Table 51. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product
    Table 53. Amicus Therapeutics Inc Recent Developments/Updates
    Table 54. Audentes Therapeutics Inc Corporation Information
    Table 55. Audentes Therapeutics Inc Description and Business Overview
    Table 56. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product
    Table 58. Audentes Therapeutics Inc Recent Developments/Updates
    Table 59. Etubics Corp Corporation Information
    Table 60. Etubics Corp Description and Business Overview
    Table 61. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Etubics Corp Lysosomal Alpha Glucosidase Product
    Table 63. Etubics Corp Recent Developments/Updates
    Table 64. Genzyme Corp Corporation Information
    Table 65. Genzyme Corp Description and Business Overview
    Table 66. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Genzyme Corp Lysosomal Alpha Glucosidase Product
    Table 68. Genzyme Corp Recent Developments/Updates
    Table 69. greenovation Biotech GmbH Corporation Information
    Table 70. greenovation Biotech GmbH Description and Business Overview
    Table 71. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product
    Table 73. greenovation Biotech GmbH Recent Developments/Updates
    Table 74. Huons Co Ltd Corporation Information
    Table 75. Huons Co Ltd Description and Business Overview
    Table 76. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Huons Co Ltd Lysosomal Alpha Glucosidase Product
    Table 78. Huons Co Ltd Recent Developments/Updates
    Table 79. JCR Pharmaceuticals Co Ltd Corporation Information
    Table 80. JCR Pharmaceuticals Co Ltd Description and Business Overview
    Table 81. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product
    Table 83. JCR Pharmaceuticals Co Ltd Recent Developments/Updates
    Table 84. Oxyrane Belgium NV Corporation Information
    Table 85. Oxyrane Belgium NV Description and Business Overview
    Table 86. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product
    Table 88. Oxyrane Belgium NV Recent Developments/Updates
    Table 89. Pharming Group NV Corporation Information
    Table 90. Pharming Group NV Description and Business Overview
    Table 91. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Pharming Group NV Lysosomal Alpha Glucosidase Product
    Table 93. Pharming Group NV Recent Developments/Updates
    Table 94. Sarepta Therapeutics Inc Corporation Information
    Table 95. Sarepta Therapeutics Inc Description and Business Overview
    Table 96. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product
    Table 98. Sarepta Therapeutics Inc Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Lysosomal Alpha Glucosidase Distributors List
    Table 102. Lysosomal Alpha Glucosidase Customers List
    Table 103. Lysosomal Alpha Glucosidase Market Trends
    Table 104. Lysosomal Alpha Glucosidase Market Drivers
    Table 105. Lysosomal Alpha Glucosidase Market Challenges
    Table 106. Lysosomal Alpha Glucosidase Market Restraints
    Table 107. Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 108. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Lysosomal Alpha Glucosidase Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 112. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Lysosomal Alpha Glucosidase Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Lysosomal Alpha Glucosidase Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 116. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Lysosomal Alpha Glucosidase Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Lysosomal Alpha Glucosidase
    Figure 2. Global Lysosomal Alpha Glucosidase Market Share by Type in 2021 & 2028
    Figure 3. AT-982 Product Picture
    Figure 4. ATB-200 Product Picture
    Figure 5. AVRRD-03 Product Picture
    Figure 6. JR-162 Product Picture
    Figure 7. MOSS-GAA Product Picture
    Figure 8. OXY-2810 Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Lysosomal Alpha Glucosidase Market Share by Application in 2021 & 2028
    Figure 11. Glycogen Storage Disease
    Figure 12. Pompe Disease
    Figure 13. Others
    Figure 14. Global Lysosomal Alpha Glucosidase Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Lysosomal Alpha Glucosidase Market Size (2017-2028) & (US$ Million)
    Figure 16. Global Lysosomal Alpha Glucosidase Sales (2017-2028) & (K Pcs)
    Figure 17. Lysosomal Alpha Glucosidase Sales Share by Manufacturers in 2021
    Figure 18. Global Lysosomal Alpha Glucosidase Revenue Share by Manufacturers in 2021
    Figure 19. The Global 5 and 10 Largest Lysosomal Alpha Glucosidase Players: Market Share by Revenue in 2021
    Figure 20. Lysosomal Alpha Glucosidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)
    Figure 22. Global Lysosomal Alpha Glucosidase Sales Market Share by Region in 2021
    Figure 23. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2017-2022)
    Figure 24. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region in 2021
    Figure 25. U.S. Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Canada Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Germany Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. France Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. U.K. Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Italy Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Russia Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Japan Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. South Korea Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. India Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Australia Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Taiwan Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Indonesia Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Thailand Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Malaysia Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Philippines Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Vietnam Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Mexico Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Brazil Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Argentina Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Turkey Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Saudi Arabia Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. UAE Lysosomal Alpha Glucosidase Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Sales Market Share of Lysosomal Alpha Glucosidase by Type (2017-2022)
    Figure 50. Manufacturing Cost Structure of Lysosomal Alpha Glucosidase
    Figure 51. Manufacturing Process Analysis of Lysosomal Alpha Glucosidase
    Figure 52. Lysosomal Alpha Glucosidase Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
Frequently Asked Questions
Lysosomal Alpha Glucosidase report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lysosomal Alpha Glucosidase report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lysosomal Alpha Glucosidase report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Glucosylceramidase

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More